About Süyen Lab

Süyen Lab was founded by Prof. Dr. Güldal Süyen and brings together researchers from diverse disciplines, including medicine, engineering, veterinary medicine, and biology.

Led by Prof. Dr. Süyen, the research team focuses primarily on neurological diseases, with particular emphasis on epilepsy and autism. In the field of epilepsy, the laboratory aims to contribute to biomarker discovery and the development of new treatment approaches. To achieve these goals, the team conducts behavioral studies alongside research utilizing advanced technologies such as Nuclear Magnetic Resonance (NMR).

In addition to their research activities, Prof. Dr. Süyen and her team mentor enthusiastic medical students and actively support young researchers with an interest in the field of neurophysiology.

Ongoing Projects

Identification of Potential Biomarkers of Epileptogenesis Through Metabolomic Profiling Using Nuclear Magnetic Resonance (NMR) Spectroscopy in a Lithium–Pilocarpine-Induced Temporal Lobe Epilepsy Rat Model
ABAPKO, 2023-2024
Investigation of the Effects of Cytidine 5′-Diphosphocholine and Uridine Monophosphate in a Valproic Acid-Induced Rat Model of Autism
ABAPKO, 2024-2025
Evaluation of Neuronal Activity and Cognitive/Behavioral Changes During the Juvenile Stage in a Pentylenetetrazole-Induced Seizure Model in Zebrafish
Conducted in collaboration with the Kavli Institute for Systems Neuroscience (Norway) under the TÜBİTAK 2214-A International Research Fellowship Program
Effects of the Dual Leucine Zipper Kinase Inhibitor GNE-3511 on Epileptogenesis and Cognitive–Behavioral Changes in a Pilocarpine-Induced Temporal Lobe Epilepsy Mouse Model
Conducted in collaboration with the University of California, San Diego (UC San Diego) under the TÜBİTAK 2214-A International Research Fellowship Program